Because it has been shown that brain natriuretic peptide (BNP) is linked to the pathophysiology of HF2, 3 and that higher plasma BNP levels qualitatively predict more frequent clinical events, such as hospitalization or cardiovascular death, clinicians refer to the plasma BNP levels when diagnosing or treating CHF patients4, 5. Here, NPPB is linked to congestive heart failure.